LONDON, July 10, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX) today closed its previously announced exercise of certain outstanding preferred investment options to purchase up to an aggregate of 548,000 ordinary shares of the Company, par...
Hence then, the article about virax biolabs group limited announces closing of exercise of preferred investment options for 3 3 million gross proceeds was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds )
Also on site :
- Inflatable Tanning Pool Loungers Are Going Viral, and Amazon’s ‘Super Comfy’ $28 Version Is a Shopper Favorite
- Netflix's 'Little House on the Prairie' Showrunner Reveals the Hardest Scene to Adapt — and Why She Rewrote It (Exclusive)
- TheWell Bioscience Launches RocketCell™ Cell Viability Enhancer to Improve Cell Recovery, Survival, and Expansion Following Passaging, Cryopreservation, and Organoid Harvesting